Literature DB >> 30302570

Density functional theory studies on a non-covalent interaction system: hydrogen-bonded dimers of zoledronate.

Qingzhu Liu1, Ke Li1, Gaochao Lv1, Xi Li1, Ying Peng1, Jianguo Lin2, Ling Qiu3.   

Abstract

A computational study was carried out to characterize the hydrogen-bonded dimers of Zoledronate (ZOL), which is used widely in treating skeletal diseases. The stable conformations, hydrogen bonding interactions, IR spectra, thermodynamic properties, and electronic characteristics of nine possible ZOL dimers were studied using density functional theory (DFT) at the B3LYP/6-311++G** level. The stability of dimers was determined according to the analyses of total electronic energies and hydrogen bonding interactions. The results showed that both the number and intensity of hydrogen bonds played an important role in determining the stability order of dimers, and the hydrogen bonding interactions in dimers resulted in a red shift of hydroxyl vibration with a corresponding increase in intensity. The calculated thermodynamic properties illustrated that the dimerization process can take place spontaneously at room temperature. Natural bond orbital and atoms in molecules analyses revealed that the nature of hydrogen bonding interactions was attributed to the interactions from lone pair orbital n(A) to the antibonding orbital σ*(D-H), and the interactions were closed-shell interactions in hydrogen-bonded dimers of ZOL. Graphical abstract Changes in Gibbs free energy and infrared spectra of ZL in the dimerization process.

Entities:  

Keywords:  DFT; Hydrogen bonding interaction; Stability; Thermodynamic property; Zoledronate dimer

Year:  2018        PMID: 30302570     DOI: 10.1007/s00894-018-3826-1

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  29 in total

Review 1.  "Strong" hydrogen bonds in chemistry and biology.

Authors:  C L Perrin; J B Nielson
Journal:  Annu Rev Phys Chem       Date:  1997       Impact factor: 12.703

2.  Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer.

Authors:  Francesco Dieli; David Vermijlen; Fabio Fulfaro; Nadia Caccamo; Serena Meraviglia; Giuseppe Cicero; Andrew Roberts; Simona Buccheri; Matilde D'Asaro; Nicola Gebbia; Alfredo Salerno; Matthias Eberl; Adrian C Hayday
Journal:  Cancer Res       Date:  2007-08-01       Impact factor: 12.701

3.  New scale factors for harmonic vibrational frequencies using the B3LYP density functional method with the triple-zeta basis set 6-311+G(d,p).

Authors:  M P Andersson; P Uvdal
Journal:  J Phys Chem A       Date:  2005-03-31       Impact factor: 2.781

Review 4.  The relationship between the chemistry and biological activity of the bisphosphonates.

Authors:  Frank H Ebetino; Anne-Marie L Hogan; Shuting Sun; Maria K Tsoumpra; Xuchen Duan; James T Triffitt; Aaron A Kwaasi; James E Dunford; Bobby L Barnett; Udo Oppermann; Mark W Lundy; Alan Boyde; Boris A Kashemirov; Charles E McKenna; R Graham G Russell
Journal:  Bone       Date:  2011-04-09       Impact factor: 4.398

5.  Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate.

Authors:  David Hosking; Kenneth Lyles; Jacques P Brown; William D Fraser; Paul Miller; Manuel Diaz Curiel; Jean-Pierre Devogelaer; Michael Hooper; Guoqin Su; Ken Zelenakas; Judy Pak; Taiwo Fashola; Youssef Saidi; Erik Fink Eriksen; Ian R Reid
Journal:  J Bone Miner Res       Date:  2007-01       Impact factor: 6.741

6.  Durability of Response to Zoledronate Treatment and Competing Mortality in Paget's Disease of Bone.

Authors:  Tim Cundy; Katherine Maslowski; Andrew Grey; Ian R Reid
Journal:  J Bone Miner Res       Date:  2016-11-30       Impact factor: 6.741

7.  The Intramolecular Hydrogen Bond N-H···S in 2,2'-Diaminodiphenyl Disulfide: Experimental and Computational Thermochemistry.

Authors:  Fernando Ramos; Henoc Flores; Julio M Hernández-Pérez; Jacinto Sandoval-Lira; E Adriana Camarillo
Journal:  J Phys Chem A       Date:  2017-12-26       Impact factor: 2.781

8.  Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results.

Authors:  R Coleman; R de Boer; H Eidtmann; A Llombart; N Davidson; P Neven; G von Minckwitz; H P Sleeboom; J Forbes; C Barrios; A Frassoldati; I Campbell; O Paija; N Martin; A Modi; N Bundred
Journal:  Ann Oncol       Date:  2012-10-09       Impact factor: 32.976

9.  Solvent effect on molecular structure, IR spectra, thermodynamic properties and chemical stability of zoledronic acid: DFT study.

Authors:  Qingzhu Liu; Ling Qiu; Yang Wang; Gaochao Lv; Guiqing Liu; Shanshan Wang; Jianguo Lin
Journal:  J Mol Model       Date:  2016-03-18       Impact factor: 1.810

10.  Zoledronic acid directly suppresses cell proliferation and induces apoptosis in highly tumorigenic prostate and breast cancers.

Authors:  Hussain Almubarak; Antonia Jones; Risa Chaisuparat; Ming Zhang; Timothy F Meiller; Mark A Scheper
Journal:  J Carcinog       Date:  2011-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.